Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Science Translational Medicine|July 24, 2010
Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac diseaseJason A Tye-Din, Jessica A Stewart, James A Dromey, et al.Nature Structural & Molecular Biology|December 25, 2019
T cell receptor cross-reactivity between gliadin and bacterial peptides in celiac diseaseJan Petersen, Laura Ciacchi, Mai T Tran, et al.BMC Medicine|August 29, 2013
A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathwaysRobert P Anderson, Margaret J Henry, Roberta Taylor, et al.The Journal of Allergy and Clinical Immunology|March 12, 2017
Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac diseaseLaura Cook, C Mee Ling Munier, Nabila Seddiki, et al.Science Advances|August 29, 2019
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac diseaseGautam Goel, Jason A Tye-Din, Shuo-Wang Qiao, et al.Frontiers in Immunology|June 7, 2021
A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac DiseaseMelinda Y Hardy, Gautam Goel, Amy K Russell, et al.Nature Structural & Molecular Biology|April 30, 2014
T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac diseaseJan Petersen, Veronica Montserrat, Jorge R Mujico, et al.Immunity|October 16, 2012
Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac diseaseSophie E Broughton, Jan Petersen, Alex Theodossis, et al.Gastroenterology|August 11, 2024
Gluten-Dependent Activation of CD4+ T Cells by MHC Class II-Expressing EpitheliumSara Rahmani, Heather J Galipeau, Alexandra V Clarizio, et al.The Lancet. Gastroenterology & Hepatology|May 17, 2017
Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studiesGautam Goel, Tim King, A James Daveson, et al.Pageof 7